Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06935253Recruiting
AI to Improve Cardiology Care
This trial tests whether large language models (a type of AI that understands human language) can help cardiologists give better care. If you are a qualified cardiologist who currently treats patients, you may be eligible.
Palo Alto, CaliforniaAges 18 years+ - NCT01551563Recruiting
Study for people newly diagnosed with inflammatory bowel disease
This trial studies treatment approaches for inflammatory bowel disease (IBD) in people who are newly diagnosed. It may help researchers find better care by learning how well the study treatment works early in the disease.
StavangerAges 16–80 - NCT06973408Recruiting
Diet and lifestyle study for weight management
This study tests whether a specific diet and behavior program can help people with overweight improve their health. You will be asked to follow a specific eating plan and eat certain foods provided by the researchers.
GothenburgAges 18–70 - NCT05724641Recruiting
MRI test of eye blood flow in specific optic nerve conditions
This study uses a special MRI scan to measure blood flow to the eye and check how consistently the results match over time. It may help doctors better assess certain optic nerve problems, especially in people without major cardiovascular risk factors.
Brussels, Brussels CapitalAges 18 years+ - NCT06251115Recruiting
Study of QY-1-T for advanced HBV-related liver cancer
This study tests a new treatment called QY-1-T for people with advanced liver cancer related to hepatitis B. It is for patients who have already tried other standard treatments and have a certain genetic marker (HLA-A*11:01).
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06668454Recruiting
Chemoimmunotherapy before surgery for limited spread esophageal cancer
This trial tests a treatment plan that combines chemotherapy with immunotherapy, followed by surgery, for people whose esophageal or stomach cancer has spread to a few areas (oligometastatic). The goal is to see if this approach can shrink the cancer and improve outcomes.
Toronto, OntarioAges 18–80 - NCT06893068Recruiting
Smart health management trial for community care
This trial tests a smart management system to improve care at community health centers. If you get care at a community clinic, you may be able to join.
Wuxi, JiangsuAges 18 years+ - NCT06923410Recruiting
Testing a smart language system for doctors and patients
This trial tests a smart computer system that helps doctors work with patients in different languages. It needs both doctors and volunteers who act like patients to see how well the system works.
Beijing, Beijing MunicipalityAges 18–80 - NCT06967792Recruiting
Safety of Terahertz Eye Scan for Blind Eyes
This trial tests a new scanning system that uses safe terahertz waves to look at the cornea. It's for people who are blind in one eye but have a healthy cornea, to see if the scan is safe.
Singapore, SingaporeAges 21 years+ - NCT07079358Recruiting
Helping veterans get cardiac rehab after a heart event
This study tests ways to increase the number of veterans who attend cardiac rehabilitation (a program of exercise and education for heart health) after a heart attack, stent procedure, valve surgery, bypass surgery, or heart failure. The goal is to make it easier for veterans to get the care they need.
Gainesville, FloridaAges 18 years+ - NCT07081841Enrolling by invitation
Long-term follow-up for AB-1005 study participants
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
San Francisco, CaliforniaAges Any age - NCT07077681Recruiting
Switching from Stelara to a biosimilar for Crohn's disease
This study checks if it's acceptable for people with Crohn's disease to switch from the biologic medicine Stelara to a similar, lower-cost version called Uzpruvo. If you have been stable on Stelara for at least 6 months without needing steroids, you may be able to participate.
AmiensAges 18 years+ - NCT07085104RecruitingPhase 1
Study of ALLO-329 for lupus, myositis, or scleroderma
This trial tests a new one-time cell therapy (ALLO-329) made from donor cells to target and calm overactive immune cells in people with lupus, myositis, or scleroderma that hasn't improved with usual medications. It aims to see if this treatment is safe and can help reduce disease activity.
Phoenix, ArizonaAges 18–74 - NCT07085533Recruiting
A Study of Inherited Retinal Diseases
This study is looking at how inherited retinal diseases affect color vision over time. It may help researchers understand these conditions better and is a good fit for people with a known diagnosis who can describe what they see.
WuhanAges Any age - NCT07078422Recruiting
Can a wrist device reduce hand tremors at home?
This study tests a wrist-worn device that uses gentle mechanical stimulation to help control hand tremors caused by essential tremor or Parkinson's disease. You use the device at home and report how well it works for you.
Cambridge, MassachusettsAges 18 years+ - NCT07078344RecruitingPhase 2
Omega-3 study for healthy African American and European American adults
This study tests whether taking omega-3 supplements can improve health and reduce diet-related differences between African American and European American adults. You would take daily capsules and visit the clinic regularly for about 6 months.
Tucson, ArizonaAges 18–64 - NCT07083531Recruiting
Bone health study for older Black women with sickle cell trait
This study looks at how carrying the sickle cell trait (not the disease) affects bone density, physical function, and frailty in older African American women. It aims to help understand bone loss risk and prevent fractures.
Farmington, ConnecticutAges 50 years+ - NCT07079995Recruiting
Healthy School Program for Texas Students
This trial looks at a program called 'Healthy School Recognized Campus' to help schools in Central and East Texas improve student health. It tests how well the program works and how schools can use it, and your child may be able to join if they are in a public school in certain grades.
Dallas, TexasAges 8–16 - NCT07082595Recruiting
Personalized brain stimulation to improve walking in Parkinson's
This study tests a personalized brain stimulation system to help improve walking and balance in people with Parkinson's. If you have trouble with gait and posture despite treatment, this trial may explore whether a tailored stimulation loop can offer additional benefit.
Zurich, Canton of ZurichAges 18 years+ - NCT07076238Recruiting
Phage therapy for hard-to-treat bacterial infections
This study looks at how well phage therapy works for people with stubborn bacterial infections, like NTM. If your doctor is already considering phage therapy as part of your care, this trial may help track your response.
New York, New YorkAges 18 years+ - NCT07077811Enrolling by invitation
Pulsed field ablation for heart failure with preserved pumping strength
This trial tests a new procedure called pulsed field ablation for people who have both persistent atrial fibrillation and a type of heart failure (HFpEF). It aims to see if this ablation safely helps control the heart rhythm.
Nantong, JiangsuAges 18–80 - NCT07085676RecruitingPhase 1
CAR-T cell therapy for autoimmune diseases that resist treatment
This study tests a new cell therapy called CAR-T (using your own immune cells) for people with severe autoimmune diseases like lupus, scleroderma, or myositis that have not improved with standard treatments. The goal is to see if it can safely reduce disease activity.
JerusalemAges 18–80 - NCT07075770Recruiting
New magnetic and electrical brain stimulation for mild Alzheimer's
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
Rome, ItalyAges 50–85 - NCT07075861Recruiting
A study of a new heart valve for people too sick for surgery
This study is testing a new valve device (JenaValve Trilogy) that can be placed without open-heart surgery. It may be an option for people whose heart team says regular valve replacement surgery is too risky.
San Donato Milanese, MilanoAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.